About ICON plc

ICON provides outsourced clinical development and commercialisation services to pharmaceutical, biotechnology, medical device, and public health organisations worldwide. With expertise spanning every phase of product development, ICON helps clients reduce time to market, lower costs, and maintain the highest quality standards through innovative AI driven solutions and patient centred trial design. Operating across 106 locations in 55 countries, ICON supports over 8,000 biotech professionals and delivers end to end capabilities from early phase research to market access. The organisation's proactive, insight led approach transforms complex regulatory challenges into streamlined pathways, ensuring life changing therapies reach patients faster.